Log in to save to my catalogue

Efficacy and safety of long-term immunotherapy in adult patients with MOG antibody disease: a system...

Efficacy and safety of long-term immunotherapy in adult patients with MOG antibody disease: a system...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2591876233

Efficacy and safety of long-term immunotherapy in adult patients with MOG antibody disease: a systematic analysis

About this item

Full title

Efficacy and safety of long-term immunotherapy in adult patients with MOG antibody disease: a systematic analysis

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Journal of neurology, 2021-12, Vol.268 (12), p.4537-4548

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Objective
To summarise the evidence of the efficacy and safety of current long-term immunotherapies in patients with myelin oligodendrocyte glycoprotein antibody disease (MOG-AD).
Methods
We performed a sensitive literature search in MEDLINE and EMBASE for selected studies or case series discussing the long-term treatments and outcomes in...

Alternative Titles

Full title

Efficacy and safety of long-term immunotherapy in adult patients with MOG antibody disease: a systematic analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2591876233

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2591876233

Other Identifiers

ISSN

0340-5354

E-ISSN

1432-1459

DOI

10.1007/s00415-020-10236-4

How to access this item